Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Palatin TechnologiesFRA:PTN 19 Current Ratio is 5.04 as of Mar. 2026, which is 141% above its 10-year median of 2.09. GuruFocus rates FRA:PTN with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 1,411 Biotechnology companies, Palatin Technologies ranks better than 57.97% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Palatin Technologies's current ratio for the quarter that ended in Mar. 2026 was 5.04.
Palatin Technologies has a current ratio of 5.04. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Palatin Technologies's Current Ratio or its related term are showing as below:
FRA:PTN'
s Current Ratio Range Over the Past 10 Years
Min: 0.26 Med: 2.09 Max: 67.08
Current: 5.04
During the past 13 years, Palatin Technologies's highest Current Ratio was 67.08. The lowest was 0.26. And the median was 2.09.
FRA:PTN's Current Ratio is ranked better than 57.97% of 1411
companies
in the Biotechnology industry
Industry Median: 3.88
vs FRA:PTN: 5.04
Palatin Technologies (FRA:PTN) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Palatin Technologies Current Ratio Related Terms
Palatin Technologies Current Ratio Historical Data
* Premium members only.
The historical data trend for Palatin Technologies's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PTN vs LPCN, NCEL, CLRB: Current Ratio Comparison
For the Biotechnology subindustry, Palatin Technologies's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Palatin Technologies Current Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Palatin Technologies's Current Ratio distribution charts can be found below:
* The bar in red indicates where Palatin Technologies's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Palatin Technologies (FRA:PTN) has a Current Ratio of 5.04 as of Mar. 2026. This is 141% above median its historical median of 2.09. Over the past decade, Palatin Technologies' Current Ratio has ranged from 0.26 to 67.08. According to the industry distribution chart, Palatin Technologies ranks #593 out of 1411 companies in the Biotechnology industry, placing it in the top 42%.
Is Palatin Technologies' Current Ratio too high?
Palatin Technologies' current Current Ratio of 5.04 is 141% above median its 10-year median of 2.09. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 67.08. The Biotechnology industry median Current Ratio is 3.88. Palatin Technologies' value of 5.04 is 29.9% above this industry median. Based on the distribution chart, Palatin Technologies ranks #593 out of 1411 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Palatin Technologies has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Palatin Technologies' Current Ratio compare to LPCN and NCEL?
According to the Biotechnology industry distribution chart, Palatin Technologies ranks #593 out of 1411 companies for Current Ratio. This puts Palatin Technologies in the upper half of its industry. The industry median Current Ratio is 3.88. Palatin Technologies' value of 5.04 is 29.9% above this benchmark. Historically, Palatin Technologies' own Current Ratio has ranged from 0.26 to 67.08 over the past decade. While the company's 10-year median is 2.09 vs. the industry median of 3.88, Palatin Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.88, based on 1,411 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Palatin Technologies's current Current Ratio of 5.04 is 29.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Palatin Technologies's current Current Ratio is 5.04, which is 141% above median its own 10-year median of 2.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Palatin Technologies stock overvalued right now?
Palatin Technologies (FRA:PTN) has a current Current Ratio of 5.04. The current Current Ratio is 5.04, which is 141% above median its 10-year median of 2.09 and 29.9% above the Biotechnology industry median of 3.88. Palatin Technologies' overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Palatin Technologies (FRA:PTN), the current Current Ratio is 5.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
19GF Score
Get the complete analysis for FRA:PTN
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PTN has been successfully added to your 
